A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68)

被引：0

作者：

P. M. Clarke

A. M. Gray

A. Briggs

A. J. Farmer

P. Fenn

R. J. Stevens

D. R. Matthews

I. M. Stratton

R. R. Holman

机构：

[1] University of Oxford,Health Economics Research Centre, Department of Public Health

[2] University of Oxford,Department of Primary Health Care

[3] University of Nottingham,Business School

[4] Churchill Hospital,Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism

[5] Churchill Hospital,Oxford Centre for Diabetes, Endocrinology and Metabolism

来源：

Diabetologia | 2004年 / 47卷

关键词：

Blood glucose; Diabetes; Diabetes-related complications; Economic evaluation; Life expectancy; Quality-adjusted life years; Risk equation simulation model; UKPDS;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1747 / 1759

页数：12

共 50 条

[1] A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68)
Clarke, PM
Gray, AM
Briggs, A
Farmer, AJ
Fenn, P
Stevens, RJ
Matthews, DR
Stratton, IM
Holman, RR
DIABETOLOGIA, 2004, 47 (10) : 1747 - 1759
[2] UKPDS Outcomes Model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82
Hayes, A. J.
Leal, J.
Gray, A. M.
Holman, R. R.
Clarke, P. M.
DIABETOLOGIA, 2013, 56 (09) : 1925 - 1933
[3] UKPDS Outcomes Model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82
A. J. Hayes
J. Leal
A. M. Gray
R. R. Holman
P. M. Clarke
Diabetologia, 2013, 56 : 1925 - 1933
[4] External validation of the UKPDS Outcomes Model equations (UKPDS 68), and the UKPDS risk engine equations (UKPDS 56 and 60) in forecasting cardiovascular outcomes in people with type 2 diabetes
McEwan, P
Bergenheim, K
Currie, CJ
VALUE IN HEALTH, 2006, 9 (03) : A37 - A38
[5] The United Kingdom Prospective Diabetes Study (UKPDS) implications for the pharmacotherapy of type 2 diabetes mellitus
Bretzel, RG
Voigt, K
Schatz, H
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1998, 106 (05) : 369 - 372
[6] EVALUATING THE EFFECTS OF THE UNITED KINGDOM PROSPECTIVE DIABETES STUDY (UKPDS) OUTCOMES MODEL RISK FACTOR PROGRESSION EQUATIONS ON COST-UTILITY OUTCOMES IN TYPE 2 DIABETES: ANALYSES USING THE PRIME DIABETES MODEL
Pollock, R. F.
Valentine, W. J.
VALUE IN HEALTH, 2022, 25 (12) : S79 - S79
[7] Modelling health outcomes in terms of quality adjusted life years: A simulation model based on the United Kingdom prospective diabetes study (UKPDS)
Clarke, P
Gray, A
Stevens, R
Stratton, I
Fenn, P
Holman, R
DIABETES, 2003, 52 : A10 - A10
[8] Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64)
Adler, AI
Stevens, RJ
Manley, SE
Bilous, RW
Cull, CA
Holman, RR
KIDNEY INTERNATIONAL, 2003, 63 (01) : 225 - 232
[9] Ethnicity and clinical outcomes in patients with type 2 diabetes in the UKPDS
Cull, CA
Davis, TME
Holman, RR
DIABETES, 2001, 50 : A220 - A220
[10] Risk factors for stroke in type 2 diabetes mellitus - United Kingdom prospective diabetes study (UKPDS) 29
Davis, TME
Millns, H
Stratton, IM
Holman, RR
Turner, RC
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (10) : 1097 - 1103

← 1 2 3 4 5 →